<DOC>
	<DOCNO>NCT00765284</DOCNO>
	<brief_summary>To determine whether 8 week Niaspan treatment increase cholesterol efflux male subject low HDL-C cholesterol compare treatment . To determine whether 8 week Niaspan treatment increase fecal cholesterol excretion compare treatment . To determine whether 8 week Niaspan treatment increase rate global reverse cholesterol transport compare treatment .</brief_summary>
	<brief_title>Effect Niaspan Cholesterol Men</brief_title>
	<detailed_description>This single center , open-label , randomize , mechanism action study consist 8 week active treatment precede screen phase one 8 week baseline measurement parameter reverse cholesterol transport 10 day . The population trial 15 non-diabetic men age 18-70 year . Ten subject low HDL-C male volunteer receive aspirin Niaspan five subject low HDL-C male volunteer receive aspirin .</detailed_description>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Subjects meet follow criterion Screening Visit eligible participate : Provide write informed consent Male Age 18 70 year BMI 18.540 kg/m2 HDLC value &lt; 40 mg/dL Triglyceride value 150500 mg/dL . Good health base medical history , physical examination laboratory safety test perform screen visit prior initial dose study medication . No clinically significant abnormality ECG perform screen visit prior initial dose study medication . Nonsmoker use nicotine contain product least 6 month plan begin smoke course study . Dietary nutritional remedy include plant sterol contain product ( i.e . Benecol , SmartBalance , etc ) sort least 2 week prior throughout study . Willing avoid use lipid modifying medication ( exclude statin ) fibrates , cholestyramine , fish oil , ezetimibe within 8 week prior study . Avoidance extreme change physical activity screen followup period . Subjects exclude participation study follow criterion apply : History intolerance Niacin Niaspan . Treatment Niacin Niaspan past 3 month ( Multivitamin use nonpharmacologic dos Niacin le 500mg per day allow ) . History stroke , chronic seizure , major neurological disorder . Significant emotional problem history clinically significant psychiatric disorder . Bleeding diathesis intolerance aspirin . Anemia define hematocrit &lt; 25 % . History gastritis , bleed gastric duodenal ulcer . History Type 1 Type 2 diabetes , fast plasma glucose &gt; 125 mg/dL screen 75 gm OGTT 2 hour glucose &gt; 140mg/dL . History illness , opinion investigator , might confound result study pose additional risk participation . History ileal bypass , gastric bypass , condition associate malabsorption . Abnormal thyroid function test . AST ALT &gt; 1.5x upper limit normal . Active recent gastrointestinal condition gastroenteritis , irritable bowel syndrome , chronic constipation , diarrhea may affect bowel movement . History plant sterol storage disease history intolerance plant sterols plant sterol contain product . History neoplastic disease ( i.e . leukemia , lymphoma , malignant melanoma ) , myeloproliferative disease , regardless time since treatment . Exceptions include adequately treat nonmelanomatous skin carcinoma , malignancy may treat successfully &gt; 10 year prior screen visit evidence recurrence . Excessive alcohol consumption define &gt; three glass alcoholic beverage distil spirit per day . *** Must avoid excessive alcohol consumption throughout study . Currently use psyllium fiber base laxative , phytosterol margarine , and/or counter ( OTC ) treatment know affect serum lipid NOT treat stable regimen &gt; 6 week prior screen ( Visit 1 ) subject DOES NOT agree continue regimen duration clinical trial . Regular user illicit drug history drug abuse ( include alcohol ) within previous 2 year . Use anabolic agent . Any condition therapy , opinion investigator , pose risk subject Use investigational drug within 30 day screen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>HDL</keyword>
	<keyword>RCT</keyword>
	<keyword>Cholesterol</keyword>
</DOC>